Customizing your treatment through precision medicine.

Translational research by definition brings knowledge from bench to bedside to offer as early as possible advanced options in difficult to treat cancers. This includes a strong dedication from John Theurer Cancer Center to customize treatment through precision medicine.

Dr. David Siegel Discusses Advances in the Treatment of Multiple Myeloma


Hear how John Theurer Cancer Center is decreasing the failure of multiple myeloma treatments from Dr. Siegel.

Our Experts

Tumor Registry

The Tumor Registry (also called the Cancer Registry) is a data source for the John Theurer Cancer Center for all reportable tumors that are diagnosed and/or treated at our facility. The Tumor Registry is staffed by certified tumor registrars (CTR) and administrative staff who are data management experts.

These experts interpret and collect a wide range of demographic, diagnostic, treatment, and follow-up information. This information is then submitted to state and national registries for use in research, treatment and prevention initiatives. John Theurer Cancer Center physicians, researchers and healthcare administrators rely on these data to determine cancer patient populations and trends, measure outcomes and formulate plans for quality improvement.

Tissue and Tumor Bank

The Tissue and Tumor Bank stores tissue, blood and bone marrow samples that have been drawn from patients who give their consent after undergoing biopsies, surgery or other cancer procedures at the John Theurer Cancer Center.

Our scientists use these samples to analyze and study multiple types of human cancer, with a goal toward learning more about how cancer develops, developing innovative new treatments and determining how well a treatment is performing.

Our Tissue Bank is overseen by our chair, Andre Goy, M.D., M.S. and our scientific director, K. Stephen Suh, Ph.D. Currently, 30 percent of our Tissue Bank team members work in our patient-care clinics, and 70 percent of our team works “behind the scenes,” dedicated 100 percent to important scientific research.